On November 4th, GeLongHui reported that shanghai microport endovascular medtech(group)co.,ltd. (688016.SH) announced that in October 2024, the company did not repurchase the company's A shares through centralized bidding trading. As of October 31, 2024, the company has repurchased a total of 894,027 shares through the Shanghai Stock Exchange trading system by centralized bidding trading, accounting for 0.73% of the company's total share capital of 123,262,117 shares. The highest price for repurchase transactions was 98.13 yuan per share, the lowest price was 78.69 yuan per share, and the total amount paid was RMB 79,989,242.97 (excluding stamp duty, transaction commission and other transaction expenses).